Miami, FL – January 23, 2020 (EmergingGrowth.com NewsWire) — EmergingGrowth.com, a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth markets and companies, reports on mCig, Inc. (OTC Pink: MCIG).
mCig, Inc. operates in the cannabis industry in the United States and internationally. The company operates through four segments: Cultivation, Manufacturing and Distribution (CMD); Retail Sales; Media and Technologies; and Agriculture. The CMD segment designs, builds, engineers, and operates commercial indoor buildings, greenhouses, and modular buildings, as well as offers consulting services in the cannabis industry. The Retail Sales segment engages in the retail, distribution, and online sale of electronic cigarettes, CBD products, and vaporizers, as well as supplies for cannabis distributors, growers, and dispensaries. The Media and Technologies segment operates 420cloud, a social platform for advertising services in the cannabis and cryptocurrency markets; and provides software solutions, Website development, and other social media services. The Agriculture segment is involved in planting and growing industrial hemp.
Average daily volume for MCIG 1 million shares. Today’s news has caused the volume to increase to over 2.5 million shares in the morning hours of trading.
mCig, Inc. Press Release:
JACKSONVILLE, FL, Jan. 23, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — mCig, Inc. (OTCQB:MCIG), vertically integrated company focused on the development and commercialization of OTC, science-driven, botanical nutrigenetics targeting the endocannabinoid system today announced that the nutraceutical joint venture of the Company and BRRx Clinical Inc. is set to move forward with an LOI to supply a national independent compounding pharmacy network. BRRX Clinical will begin releasing the CBD enhanced medical foods/topical applications that are in FDA trials. The products are registered with the International Review Board. The first of these offerings will be for the treatment of shingles. The salve will be valuable not only for protocols established but for addressing the pain that accompanies this diagnosis as well. The Researcher, developer, and advisors have hit the mark in this delivery for relief and a trajectory for reversal of this diagnosis.
Dale Hipes, CEO of BRRx Clinical, states, “We are following a very strategic and well-crafted plan by our senior management team. We are looking forward to many great opportunities to affect change, be the standard for the new Healthcare modalities that Hemp-Derived treatments and capabilities bring to the marketplace.”
Paul Rosenberg, CEO of mCig, Inc., added, “Dale completely changed my view on the whole cannabis industry and the steps the Company should take in order to stay ahead of its competitors. In a few weeks, we are going to introduce our revolutionary BRRx Clinical web portal, which will allow the Company to offer some unique products that will change the lives of millions of people.”
About MCIG Group
Headquartered in Jacksonville, Florida, mCig, Inc. (MCIG) is a diversified company servicing the legal cannabis, hemp and CBD markets via its lifestyle brands.
The Company has been featured in media nationwide, including CNBC, Bloomberg, TheStreet.com. For more information, visit www.mciggroup.com.
Visit us on Facebook @ https://www.facebook.com/mCigInc/
Follow us on Twitter @mcigInc
About BareRoots Rx Inc.
The company focused on the development and commercialization of OTC, science-driven, botanical nutrigenetics, that target the endocannabinoid system. BareRoots Rx Inc. also delivers high-quality consumer and OTC THC-free CBD products that promote overall health and well being as well as state-of-the-art testing and analytics capabilities to our customers.
This press release may include predictions, estimates or other information that might be considered forward-looking within the meaning of applicable securities laws. While these forward-looking statements represent the Company’s current judgments, they are subject to risks and uncertainties that could cause actual results to differ materially. You are cautioned not to place undue reliance on these forward-looking statements, which reflect the opinions of the Company’s management only as of the date of this release. Please keep in mind that the Company is not obligating itself to revise or publicly release the results of any revision to these forward-looking statements in light of new information or future events. When used herein, words such as: potential, expect, look forward, believe, dedicated, building, or variations of such words and similar expressions are intended to identify forward-looking statements. Factors that could cause actual results to differ materially from those contemplated in any forward-looking statements made by the Company herein are often discussed in filings the Company makes with the United States Securities and Exchange Commission (SEC) available at www.sec.gov and on the Company’s website at www.mciggroup.com.
Contact: mCig, Inc. Paul Rosenberg firstname.lastname@example.org
EmergingGrowth.com is a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth markets and companies. Through its evolution, EmergingGrowth.com found a niche in identifying companies that can be overlooked by the markets due to, among other reasons, trading price or market capitalization. We look for strong management, innovation, strategy, execution, and the overall potential for long- term growth. Aside from being a trusted resource for the Emerging Growth info-seekers, we are well known for discovering undervalued companies and bringing them to the attention of the investment community. Through our parent Company, we also have the ability to facilitate road shows to present your products and services to the most influential investment banks in the space.